Natixis Advisors LLC Takes Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Natixis Advisors LLC bought a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 30,445 shares of the company's stock, valued at approximately $2,021,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Hollencrest Capital Management acquired a new position in Ryan Specialty in the third quarter worth $25,000. Assetmark Inc. acquired a new position in Ryan Specialty in the third quarter worth $34,000. GAMMA Investing LLC boosted its stake in Ryan Specialty by 96.4% in the second quarter. GAMMA Investing LLC now owns 605 shares of the company's stock worth $35,000 after purchasing an additional 297 shares in the last quarter. Crewe Advisors LLC acquired a new position in Ryan Specialty in the second quarter worth $39,000. Finally, Rothschild Investment LLC acquired a new position in shares of Ryan Specialty during the second quarter valued at $87,000. Institutional investors own 84.82% of the company's stock.

Insiders Place Their Bets

In related news, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the completion of the transaction, the executive vice president now directly owns 12,386 shares in the company, valued at approximately $884,236.54. This trade represents a 54.42 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 5,375 shares of the stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $64.73, for a total value of $347,923.75. Following the transaction, the director now owns 2,685 shares of the company's stock, valued at approximately $173,800.05. The trade was a 66.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Ryan Specialty Trading Up 0.7 %

Shares of Ryan Specialty stock traded up $0.51 during trading hours on Tuesday, hitting $75.10. The company's stock had a trading volume of 1,090,854 shares, compared to its average volume of 871,530. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $75.50. The stock has a 50 day moving average of $69.27 and a 200 day moving average of $62.80. The company has a market capitalization of $19.66 billion, a PE ratio of 97.53, a price-to-earnings-growth ratio of 1.67 and a beta of 0.62. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. During the same period in the prior year, the company earned $0.32 earnings per share. The company's revenue for the quarter was up 20.5% compared to the same quarter last year. Analysts predict that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.

Ryan Specialty Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.59%. Ryan Specialty's dividend payout ratio (DPR) is currently 57.14%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on RYAN shares. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and upped their price target for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. The Goldman Sachs Group upped their price target on Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a research note on Wednesday, October 9th. Bank of America upped their price target on Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research note on Thursday, October 10th. UBS Group upped their price target on Ryan Specialty from $67.00 to $76.00 and gave the company a "buy" rating in a research note on Tuesday, August 13th. Finally, Wells Fargo & Company upped their price objective on Ryan Specialty from $63.00 to $70.00 and gave the company an "equal weight" rating in a report on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $71.67.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.